Skip to main content

United-Guardian, Inc.

corporate_fare Company Profile

United-Guardian, Inc.

UG·NASDAQ·Industrial Applications And Services·CIK 0000101295

United-Guardian, Inc. is a Delaware corporation that manufactures, markets, and develops specialty cosmetic, personal care, and sexual wellness ingredients, along with a line of healthcare products including pharmaceuticals and medical lubricants, through its Guardian Laboratories division. The company conducts various research and development (R&D) activities, primarily focusing on new and unique specialty cosmetic and sexual wellness ingredients. A priority for many cosmetic customers is the development of new products using natural and environmentally friendly raw materials. The R&D department also modifies, refines, and expands the uses for existing products to further develop their markets. All products marketed by United-Guardian, Inc., with the exception of Renacidin®, are produced at its facility in Hauppauge, New York. Renacidin, a urological product, is manufactured by an outside contract manufacturer. The company's predecessor, United International Research, Inc. (UIR), was founded in New York in 1942. On February 10, 1982, UIR merged with Guardian Chemical Corporation, changing its name to United-Guardian, Inc., a New York corporation. On September 14, 1987, the company merged into a newly formed Delaware corporation with the same name to change its domicile to Delaware. The business emphasizes product innovation, using its development and formulation expertise to maintain market position and drive future growth. The company also focuses on developing new products with unique properties that address unmet market needs. Its products are sold into personal care, medical devices, and healthcare markets.

United-Guardian, Inc. (NASDAQ:UG) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 7 items for UG at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-08-07, rated 7/10. Across its 7 most recent items scored 7 or higher, the top rating is 8/10, with 3 rated 8 or above. Recent SEC coverage for UG spans 10-Q, 8-K, DEF 14A, 10-K.

Recent high-impact activity:

  • United-Guardian Q2 Sales Jump 10% on 44% Surge in Cosmetic Ingredient Demand
  • Q1 2026 Net Sales Up 15.7%, Net Income Jumps 46%, Despite Dividend Cut
  • United Guardian Reports Strong Q1 Sales & Earnings Growth, Reversing Prior Declines
  • United Guardian Sets Annual Meeting, Discloses Executive Pay Hike Amidst 35% Net Income Drop
  • Annual Report Reveals 13% Sales Drop, 35% Net Income Decline for Fiscal 2025

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$10.55M
Net Income
$2.11M
Op. Cash Flow
$1.97M
Free Cash Flow
$1.91M
Gross Profit
$5.14M
Operating Income
$2.24M
Cash & Equivalents
$1.25M
Debt / Equity
0.00×
Net Margin
20.0%
Shares Outstanding
4.59M sh
Source: 10-K · filed 2026-03-27 · accession 0001171843-26-001973

Short Interest & Short Volume

2.09 days to cover

FINRA reported short interest of 19,823 shares in UG as of the September 15, 2026 settlement, a 23.6% increase from the prior period — about 2.1 days to cover at its recent average daily volume. On October 2, 2026, 35.8% of UG volume reported to FINRA trade-reporting facilities was marked short.

Short interest (bi-monthly positions)19,823 shares as of September 15, 2026
Change vs prior period▲ 23.6%
Days to cover2.09 at avg daily volume of 9,470
Daily short volume (FINRA facilities)35.8% of 1,857 shares on October 2, 2026
5-day average short volume33.5%

Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.

Browse all tickers starting with U →
$7.1
52-week range · as of 2026-05-12 $5.58 – $9.88
Market cap
$32.76M
Volume
3.9K (0.5× avg)
3-mo avg 7.9K
Live data · 2026-10-03 03:18 UTC · Market overnight

show_chartPrice Chart

Loading chart...

feed UG - Latest Insights

UG
Aug 07, 2026, 10:42 AM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $7.11
Real-time Price: $7.10 info
Change: -$0.010 (-0.14%) info
Market Cap: $32.757M info
UG
May 12, 2026, 9:00 AM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $7.10
Real-time Price: $7.10 info
Change: $0 (0%) info
Market Cap: $32.757M info
UG
May 08, 2026, 9:00 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $7.00
Real-time Price: $7.10 info
Change: +$0.100 (+1%) info
Market Cap: $32.757M info
UG
Apr 06, 2026, 12:02 PM EDT
Filing Type: DEF 14A
Importance Score:
7
Price at Filing: $6.60
Real-time Price: $7.10 info
Change: +$0.500 (+8%) info
Market Cap: $32.757M info
UG
Mar 27, 2026, 9:00 AM EDT
Filing Type: 10-K
Importance Score:
8
Price at Filing: $6.25
Real-time Price: $7.10 info
Change: +$0.850 (+14%) info
Market Cap: $32.757M info
UG
Mar 27, 2026, 9:00 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $6.25
Real-time Price: $7.10 info
Change: +$0.850 (+14%) info
Market Cap: $32.757M info
UG
Jan 29, 2026, 9:00 AM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $6.64
Real-time Price: $7.10 info
Change: +$0.460 (+7%) info
Market Cap: $32.757M info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets